Targeting mitochondrial permeability transition pore ameliorates PM2.5-induced mitochondrial dysfunction in airway

Yingmin Liang1, Pak Hin Chu1, Linwei Tian2

  • 1Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.

Insights

Particulate matter (PM2.5) triggers airway injury by opening mitochondrial pores (mPTP), causing cell death. Inhibiting mPTP protected cells and preserved mitochondrial function, suggesting mPTP as a therapeutic target for PM2.5-induced respiratory damage.

Area of Science:

  • Environmental Health
  • Cell Biology
  • Toxicology

Background:

  • Particulate matter (PM2.5) exposure is linked to increased respiratory disease risk.
  • Mitochondrial dysfunction is implicated in PM2.5-induced airway injury.
  • The role of mitochondrial permeability transition pore (mPTP) in this process remains unclear.

Purpose of the Study:

  • To investigate the involvement of mPTP in PM2.5-induced mitochondrial dysfunction in airway epithelial cells.
  • To explore the therapeutic potential of mPTP inhibitors against PM2.5 toxicity.

Main Methods:

  • Exposure of BEAS-2B cells to PM2.5.
  • Assessment of cell viability, apoptosis, and mitochondrial morphology.
  • Measurement of mitochondrial membrane potential, ROS generation, and calcium levels.
  • Evaluation of mitochondrial respiratory function and ATP production.
  • Treatment with mPTP inhibitors (cyclosporin A and VBIT-12).

Main Results:

  • PM2.5 reduced cell viability and induced apoptosis, accompanied by mitochondrial damage.
  • PM2.5 triggered mPTP opening via VDAC upregulation, leading to mitochondrial dysfunction.
  • PM2.5 impaired mitochondrial respiration and ATP production.
  • CsA and VBIT-12 inhibited PM2.5-induced mPTP opening and apoptosis, restoring mitochondrial function.
  • PM2.5 decreased PPARγ and PGC-1α expression, which was reversed by CsA.

Conclusions:

  • Mitochondrial permeability transition pore (mPTP) opening is a key mechanism in PM2.5-induced airway epithelial cell injury.
  • Targeting mPTP with inhibitors like CsA and VBIT-12 shows therapeutic promise for mitigating PM2.5-related respiratory damage.
  • mPTP inhibition preserves mitochondrial function and may influence key transcriptional regulators like PPARγ and PGC-1α.